vs
Side-by-side financial comparison of Cintas (CTAS) and DaVita (DVA). Click either name above to swap in a different company.
Cintas is the larger business by last-quarter revenue ($6.4B vs $3.6B, roughly 1.8× DaVita). Cintas runs the higher net margin — 7.8% vs 6.5%, a 1.4% gap on every dollar of revenue. On growth, DaVita posted the faster year-over-year revenue change (12.3% vs 8.9%). Over the past eight quarters, Cintas's revenue compounded faster (61.2% CAGR vs 6.6%).
Cintas Corporation is an American corporation headquartered in Mason, Ohio, which provides a range of products and services to businesses including uniforms, mats, mops, cleaning and restroom supplies, first aid and safety products, fire extinguishers and testing, and safety courses. Cintas is a publicly held company traded on the Nasdaq Global Select Market under the symbol CTAS and is a component of the S&P 500 Index.
DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
CTAS vs DVA — Head-to-Head
Income Statement — Q4 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $6.4B | $3.6B |
| Net Profit | $502.5M | $234.2M |
| Gross Margin | 83.1% | — |
| Operating Margin | 10.3% | 15.5% |
| Net Margin | 7.8% | 6.5% |
| Revenue YoY | 8.9% | 12.3% |
| Net Profit YoY | 8.4% | 43.8% |
| EPS (diluted) | $1.24 | $3.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $6.4B | $3.6B | ||
| Q4 25 | $2.8B | $3.6B | ||
| Q3 25 | $2.7B | $3.4B | ||
| Q2 25 | $2.7B | $3.4B | ||
| Q1 25 | $2.6B | $3.2B | ||
| Q4 24 | $2.6B | $3.3B | ||
| Q3 24 | $2.5B | $3.3B | ||
| Q2 24 | $2.5B | $3.2B |
| Q1 26 | $502.5M | $234.2M | ||
| Q4 25 | $495.3M | $234.2M | ||
| Q3 25 | $491.1M | $150.3M | ||
| Q2 25 | $448.3M | $199.3M | ||
| Q1 25 | $463.5M | $162.9M | ||
| Q4 24 | $448.5M | $259.3M | ||
| Q3 24 | $452.0M | $214.7M | ||
| Q2 24 | $414.3M | $222.7M |
| Q1 26 | 83.1% | — | ||
| Q4 25 | 50.4% | — | ||
| Q3 25 | 50.3% | — | ||
| Q2 25 | 49.7% | — | ||
| Q1 25 | 50.6% | — | ||
| Q4 24 | 49.8% | — | ||
| Q3 24 | 50.1% | — | ||
| Q2 24 | — | — |
| Q1 26 | 10.3% | 15.5% | ||
| Q4 25 | 23.4% | 15.5% | ||
| Q3 25 | 22.7% | 14.8% | ||
| Q2 25 | 22.4% | 15.9% | ||
| Q1 25 | 23.4% | 13.6% | ||
| Q4 24 | 23.1% | 17.2% | ||
| Q3 24 | 22.4% | 16.4% | ||
| Q2 24 | 22.2% | 15.9% |
| Q1 26 | 7.8% | 6.5% | ||
| Q4 25 | 17.7% | 6.5% | ||
| Q3 25 | 18.1% | 4.4% | ||
| Q2 25 | 16.8% | 5.9% | ||
| Q1 25 | 17.8% | 5.1% | ||
| Q4 24 | 17.5% | 7.9% | ||
| Q3 24 | 18.1% | 6.6% | ||
| Q2 24 | 16.8% | 7.0% |
| Q1 26 | $1.24 | $3.22 | ||
| Q4 25 | $1.21 | $3.22 | ||
| Q3 25 | $1.20 | $2.04 | ||
| Q2 25 | $1.08 | $2.58 | ||
| Q1 25 | $1.13 | $2.00 | ||
| Q4 24 | $1.09 | $3.08 | ||
| Q3 24 | $1.10 | $2.50 | ||
| Q2 24 | $4.00 | $2.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $183.2M | $700.7M |
| Total DebtLower is stronger | — | $10.2B |
| Stockholders' EquityBook value | $4.8B | $-651.1M |
| Total Assets | — | $17.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $183.2M | $700.7M | ||
| Q4 25 | $200.8M | $700.7M | ||
| Q3 25 | $138.1M | $736.5M | ||
| Q2 25 | $264.0M | $739.4M | ||
| Q1 25 | $243.4M | $511.9M | ||
| Q4 24 | $122.4M | $846.0M | ||
| Q3 24 | $101.4M | $1.1B | ||
| Q2 24 | $342.0M | $437.2M |
| Q1 26 | — | $10.2B | ||
| Q4 25 | $2.4B | $10.2B | ||
| Q3 25 | $2.4B | $10.2B | ||
| Q2 25 | $2.4B | $10.1B | ||
| Q1 25 | $2.0B | $9.6B | ||
| Q4 24 | $2.0B | $9.2B | ||
| Q3 24 | $2.0B | $9.3B | ||
| Q2 24 | $2.0B | $8.5B |
| Q1 26 | $4.8B | $-651.1M | ||
| Q4 25 | $4.5B | $-651.1M | ||
| Q3 25 | $4.8B | $-571.9M | ||
| Q2 25 | $4.7B | $-369.6M | ||
| Q1 25 | $4.6B | $-267.1M | ||
| Q4 24 | $4.3B | $121.1M | ||
| Q3 24 | $4.0B | $386.7M | ||
| Q2 24 | $4.3B | $632.9M |
| Q1 26 | — | $17.5B | ||
| Q4 25 | $10.1B | $17.5B | ||
| Q3 25 | $9.8B | $17.6B | ||
| Q2 25 | $9.8B | $17.5B | ||
| Q1 25 | $9.6B | $17.1B | ||
| Q4 24 | $9.4B | $17.3B | ||
| Q3 24 | $9.1B | $17.5B | ||
| Q2 24 | $9.2B | $17.0B |
| Q1 26 | — | — | ||
| Q4 25 | 0.54× | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | 0.52× | — | ||
| Q1 25 | 0.44× | — | ||
| Q4 24 | 0.47× | 75.76× | ||
| Q3 24 | 0.50× | 23.95× | ||
| Q2 24 | 0.47× | 13.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.6B | — |
| Free Cash FlowOCF − Capex | $1.3B | — |
| FCF MarginFCF / Revenue | 19.7% | — |
| Capex IntensityCapex / Revenue | 4.7% | — |
| Cash ConversionOCF / Net Profit | 3.12× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.5B | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.6B | — | ||
| Q4 25 | $531.2M | $540.7M | ||
| Q3 25 | $414.5M | $841.5M | ||
| Q2 25 | $635.7M | $324.2M | ||
| Q1 25 | $622.0M | $180.0M | ||
| Q4 24 | $441.4M | $547.6M | ||
| Q3 24 | $466.7M | $810.4M | ||
| Q2 24 | $693.0M | $798.8M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $425.0M | $395.3M | ||
| Q3 25 | $312.5M | $675.4M | ||
| Q2 25 | $521.1M | $203.1M | ||
| Q1 25 | $522.1M | $36.8M | ||
| Q4 24 | $340.0M | $377.0M | ||
| Q3 24 | $373.8M | $671.4M | ||
| Q2 24 | $591.1M | $674.1M |
| Q1 26 | 19.7% | — | ||
| Q4 25 | 15.2% | 10.9% | ||
| Q3 25 | 11.5% | 19.7% | ||
| Q2 25 | 19.5% | 6.0% | ||
| Q1 25 | 20.0% | 1.1% | ||
| Q4 24 | 13.3% | 11.4% | ||
| Q3 24 | 14.9% | 20.6% | ||
| Q2 24 | 23.9% | 21.2% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 3.8% | 4.0% | ||
| Q3 25 | 3.8% | 4.9% | ||
| Q2 25 | 4.3% | 3.6% | ||
| Q1 25 | 3.8% | 4.4% | ||
| Q4 24 | 4.0% | 5.2% | ||
| Q3 24 | 3.7% | 4.3% | ||
| Q2 24 | 4.1% | 3.9% |
| Q1 26 | 3.12× | — | ||
| Q4 25 | 1.07× | 2.31× | ||
| Q3 25 | 0.84× | 5.60× | ||
| Q2 25 | 1.42× | 1.63× | ||
| Q1 25 | 1.34× | 1.10× | ||
| Q4 24 | 0.98× | 2.11× | ||
| Q3 24 | 1.03× | 3.77× | ||
| Q2 24 | 1.67× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
